Protective heterologous T cell immunity in COVID-19 induced by the trivalent MMR and Tdap vaccine antigensVijayashree Mysore, Tanya N. Mayadas, Xavier Culleré et al.|Med|2021Cited by 54
Activity of mRNA COVID-19 vaccines in patients with lymphoid malignanciesJennifer L. Crombie, Nicolas C. Issa, Jonathan Krauß et al.|Blood Advances|2021Cited by 24
Measurement of α-synuclein as protein cargo in plasma extracellular vesiclesTal Gilboa, David R. Walt|Proceedings of the National Academy of Sciences|2024Cited by 23
Assessment of extracellular vesicle protein cargo as neurodegenerative disease biomarkersTal Gilboa, David R. Walt|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 5
586. Immunogenicity of COVID-19 mRNA Vaccines in Patients with Lymphoid MalignanciesNatalie Izaguirre, Lindsey R. Baden, Amy C Sherman et al.|Open Forum Infectious Diseases|2021Cited by 1